27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.
Leigh Vosseller, insider at Tandem Diabetes Care

Leigh Vosseller Insider Information

Leigh Vosseller has served as our Executive Vice President, Chief Financial Officer and Treasurer since June 2018, and served as Senior Vice President, Chief Financial Officer and Treasurer from January 2018 to May 2018. Ms. Vosseller is our principal financial and accounting officer. She joined us as Vice President of Finance in 2013 and was promoted to Senior Vice President of Finance in August 2017. Prior to that time, she served as Vice President and Chief Financial Officer at Genoptix, beginning in 2011, after initially joining Genoptix in 2008. Prior to that she held a senior finance position at Biosite where she played a key role in developing the financial and administrative infrastructure for international expansion. Ms. Vosseller is a certified public accountant (inactive) and holds a BS in Accounting from Missouri State University.

What is Leigh Vosseller's net worth?

The estimated net worth of Leigh Vosseller is at least $520,010.12 as of May 6th, 2022. Ms. Vosseller owns 8,618 shares of Tandem Diabetes Care stock worth more than $520,010 as of June 29th. This net worth evaluation does not reflect any other assets that Ms. Vosseller may own. Additionally, Ms. Vosseller receives a salary of $764,640.00 as CFO at Tandem Diabetes Care. Learn More about Leigh Vosseller's net worth.

How old is Leigh Vosseller?

Ms. Vosseller is currently 49 years old. There are 7 older executives and no younger executives at Tandem Diabetes Care. The oldest executive at Tandem Diabetes Care is Mr. John F. Sheridan, Pres, CEO & Director, who is 67 years old. Learn More on Leigh Vosseller's age.

What is Leigh Vosseller's salary?

As the CFO of Tandem Diabetes Care, Inc., Ms. Vosseller earned a total compensation package of $1,957,059.00 in 2020. Ms. Vosseller earned a salary of $412,000.00, a bonus of $25,532.00, options awards of $803,352.00, non-equity compensation of $178,726.00, and other compensation of $1,910.00.There are 3 executives that earn more than Ms. Vosseller. The highest earning executive at Tandem Diabetes Care is Mr. John F. Sheridan, Pres, CEO & Director, who commands a salary of $1,600,000.00 per year. Learn More on Leigh Vosseller's salary.

How do I contact Leigh Vosseller?

The corporate mailing address for Ms. Vosseller and other Tandem Diabetes Care executives is 11075 ROSELLE STREET, San Diego CA, 92121. Tandem Diabetes Care can also be reached via phone at (858) 366-6900 and via email at [email protected] Learn More on Leigh Vosseller's contact information.

Has Leigh Vosseller been buying or selling shares of Tandem Diabetes Care?

During the past quarter, Leigh Vosseller has bought $186,520.00 in Tandem Diabetes Care stock. 0 shares of BMO Capital Markets stock in a transaction on Wednesday, June 29th. Learn More on Leigh Vosseller's trading history.

Who are Tandem Diabetes Care's active insiders?

Tandem Diabetes Care's insider roster includes David Berger (EVP), Kim Blickenstaff (Director), Elizabeth Gasser (EVP), Brian Hansen (EVP), James Leal (SVP), Kathleen McGroddy-Goetz (Director), Susan Morrison (EVP), Rebecca Robertson (Director), John Sheridan (CEO), Christopher Twomey (Director), and Leigh Vosseller (CFO). Learn More on Tandem Diabetes Care's active insiders.

Are insiders buying or selling shares of Tandem Diabetes Care?

In the last twelve months, Tandem Diabetes Care insiders bought shares 3 times. They purchased a total of 5,000 shares worth more than $361,270.00. In the last twelve months, insiders at the medical device company sold shares 40 times. They sold a total of 236,134 shares worth more than $28,911,980.10. The most recent insider tranaction occured on June, 8th when COO David B Berger sold 10,097 shares worth more than $656,506.94. Insiders at Tandem Diabetes Care own 2.2 % of the company. Learn More about insider trades at Tandem Diabetes Care.

Information on this page was last updated on 6/8/2022.

Leigh Vosseller Insider Trading History at Tandem Diabetes Care

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/9/2022Buy500$70.00$35,000.009,118View SEC Filing Icon  
5/6/2022Buy2,000$75.76$151,520.008,618View SEC Filing Icon  
11/3/2021Sell10,000$140.05$1,400,500.00View SEC Filing Icon  
10/14/2021Sell10,000$135.09$1,350,900.00View SEC Filing Icon  
10/12/2021Sell10,000$130.00$1,300,000.00View SEC Filing Icon  
9/15/2021Sell3,500$125.00$437,500.00View SEC Filing Icon  
9/13/2021Sell10,000$120.75$1,207,500.0016,145View SEC Filing Icon  
10/13/2020Sell10,000$120.87$1,208,700.0014,520View SEC Filing Icon  
7/31/2020Sell10,000$110.03$1,100,300.0014,520View SEC Filing Icon  
7/6/2020Sell10,000$105.04$1,050,400.0014,520View SEC Filing Icon  
7/2/2020Sell20,000$97.74$1,954,800.0014,520View SEC Filing Icon  
6/30/2020Sell10,000$95.04$950,400.0014,520View SEC Filing Icon  
5/7/2020Sell10,000$90.07$900,700.0013,265View SEC Filing Icon  
1/29/2020Sell10,000$75.93$759,300.0012,882View SEC Filing Icon  
11/25/2019Sell10,000$70.35$703,500.0013,265View SEC Filing Icon  
11/18/2019Sell10,000$65.41$654,100.0013,265View SEC Filing Icon  
5/16/2019Sell10,000$70.45$704,500.0012,009View SEC Filing Icon  
5/3/2019Sell10,000$65.14$651,400.0012,009View SEC Filing Icon  
See Full Table

Leigh Vosseller Buying and Selling Activity at Tandem Diabetes Care

This chart shows Leigh Vosseller's buying and selling at Tandem Diabetes Care by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Tandem Diabetes Care Company Overview

Tandem Diabetes Care logo
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $60.34
Low: $60.15
High: $62.09

50 Day Range

MA: $74.59
Low: $53.22
High: $117.39

2 Week Range

Now: $60.34
Low: $52.69
High: $155.86

Volume

744,996 shs

Average Volume

744,862 shs

Market Capitalization

$3.86 billion

P/E Ratio

754.34

Dividend Yield

N/A

Beta

0.69
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.